UBS’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$18K Buy
1,366
+164
+14% +$2.25K ﹤0.01% 8136
2014
Q2
$17K Buy
1,202
+216
+22% +$3.25K ﹤0.01% 8270
2014
Q1
$16K Sell
986
-623
-39% -$10.4K ﹤0.01% 8379
2013
Q4
$30K Sell
1,609
-1,179
-42% -$20.7K ﹤0.01% 7645
2013
Q3
$52K Buy
2,788
+2,388
+597% +$41K ﹤0.01% 6815
2013
Q2
$7K Buy
+400
New +$6.39K ﹤0.01% 8990

Other funds holding NRC

UBS's NRC Position: Q3 2014 in Review

UBS increased its NRC Health Common Stock (NRC) stake by 14% in Q3 2014, buying an estimated $2.25K and bringing the position to 1,366 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #8136.

UBS first reported a position in NRC in Q2 2013 and has held it in 6 quarters since. The position peaked at $52K in Q3 2013. 46 funds tracked by Wall St. Rank hold NRC as of Q3 2014.

  • UBS held 1,366 shares of NRC Health Common Stock worth $18K as of Q3 2014.
  • UBS bought 164 NRC Health Common Stock shares in Q3 2014, an estimated $2.25K.
  • NRC Health Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8136 holding.
  • UBS first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 6 quarters since.
  • UBS's NRC Health Common Stock position peaked at $52K in Q3 2013.
  • 46 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.